eBook: EU Orphan Drug Launch

Understanding and delivering your EU Orphan Drug Launch

 
Home / Commercial Services /

EU Orphan Drug Launch – Understanding and delivering your EU Orphan Drug Launch

Launching your product on to the European Market can present a real challenge if you are not familiar with country specific requirements. In this eBook our expert Orphan drug product launch team share their knowledge and experience regarding:

  • The EU rare disease marketplace
  • Regulatory / MA submission considerations
  • Quality requirements – EU import testing and QP release
  • Packaging design and regionalisation considerations
  • Serialisation
  • Almac’s Orphan Drug expertise
  • Almac’s Seamless Brexit Solution
This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies